title: The 'heartbreak of psoriasis' has met its match!
authors.forename: Thomas
authors.initials: T
authors.lastname: Morrow
mesh_terms: D000077944:Alefacept; D016207:Cytokines / Q000187:drug effects / Q000276:immunology; D015195:Drug Design; D006801:Humans; D016376:Oligonucleotides, Antisense / Q000627:therapeutic use; D010597:Pharmacogenetics / Q000191:economics / Q000639:trends*; D011565:Psoriasis / Q000188:drug therapy* / Q000235:genetics / Q000276:immunology / Q000503:physiopathology; D018124:Receptors, Tumor Necrosis Factor / Q000037:antagonists & inhibitors; D011993:Recombinant Fusion Proteins / Q000191:economics / Q000627:therapeutic use; D013601:T-Lymphocytes / Q000187:drug effects / Q000276:immunology; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D016207:Cytokines; D016376:Oligonucleotides, Antisense; D018124:Receptors, Tumor Necrosis Factor; D011993:Recombinant Fusion Proteins; D000077944:Alefacept